Viridian Therapeutics: Funding, Investors & Team (Oct 2026)
Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies. Viridian is developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.
Viridian Therapeutics has raised $300M across 2 funding rounds on record, the most recent an undisclosed round of $225M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Viridian Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Viridian Therapeutics Funding Rounds
Viridian Therapeutics raised $75.0M in a Post-IPO Debt announced in Apr 2022.
4.1 years later, an undisclosed round of $225M was announced in May 2026.
Viridian Therapeutics Founders and Leadership Team
Contact details for the Viridian Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Viridian Therapeutics Funding Compared to Other Biotechnology Startups
Viridian Therapeutics' latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Viridian Therapeutics in Biotechnology and Boulder
Companies Similar to Viridian Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Viridian Therapeutics Funding FAQs
What does Viridian Therapeutics do?
Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies. Viridian is developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.
How much funding has Viridian Therapeutics raised?
Viridian Therapeutics has raised $300M across 2 rounds on record. The most recent is an undisclosed round of $225M announced in May 2026.
When did Viridian Therapeutics last raise funding?
Viridian Therapeutics' most recent funding round on record is an undisclosed round of $225M, announced in May 2026.
Who founded Viridian Therapeutics?
FundedIQ lists Steve Mahoney (Founder) at Viridian Therapeutics.
Who is the CEO of Viridian Therapeutics?
Jonathan Violin is listed as CEO at Viridian Therapeutics.
Where is Viridian Therapeutics headquartered?
Viridian Therapeutics is based in Boulder, Colorado, United States.
How many employees does Viridian Therapeutics have?
Viridian Therapeutics is in the 51-100 employee band.
How does Viridian Therapeutics' funding compare to other Biotechnology startups?
Viridian Therapeutics' latest round of $225M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Viridian Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Viridian Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.